1. Scrip
  2. >>Therapy Areas

Bayer’s Stivarga First Drug To Enter Brain Cancer Platform Trial

 
• By Kevin Grogan

GBM AGILE is the first global adaptive clinical trial platform for glioblastoma and the German group's liver and colorectal cancer drug will be the first of several therapies to be studied.

Desert
Looking to make advances in brain cancer • Source: Shutterstock

Following years of failures in glioblastoma (GBM), Bayer AG is participating in an innovative platform clinical trial designed to find new treatments for the deadliest form of brain cancer, with the company's multi-kinase inhibitor Stivarga to be the first drug to be evaluated.

The German major has announced that the Stivarga (regorafenib) arm of the GBM AGILE platform trial, sponsored by the non-profit Global Coalition for Adaptive Research, has opened for enrolment in...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Anticancer

More from Therapy Areas

New Vaccine Framework Avoided Worst-Case Scenario, Analysts Say

 
• By Joseph Haas

The new US FDA vaccine guidelines introduced on 20 May might cause financial woes for Moderna, but overall vaccine makers should not be as impacted as feared.

Merck KGaA Plans Phase III For Enpatoran After Mixed Phase II Lupus Data

 
• By Jessica Merrill

The Phase II study testing the novel TLR7/8 inhibitor met the primary endpoint in a cohort of patients with cutaneous lupus erythematosus and systemic lupus erythematosus with rash, but did not in patients with SLE.

PureTech’s IPF Candidate Ready For Phase III After Efficacy Win

 
• By Andrew McConaghie

Coming one day after Boehringer’s underwhelming data, PureTech’s tweaked molecule, deupirfenidone, shows promise in slowing idiopathic pulmonary fibrosis.